TiumBio Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 8,013.45 million compared to negative sales of KRW 0.00046 million a year ago. Net loss was KRW 29,852.52 million compared to KRW 31,637.19 million a year ago.

Basic loss per share from continuing operations was KRW 1,246 compared to KRW 1,329 a year ago. Diluted loss per share from continuing operations was KRW 1,246 compared to KRW 1,329 a year ago. Basic loss per share was KRW 1,246 compared to KRW 1,329 a year ago.